An open label, randomized , crossover trial to assess the effect of food on Doravirine bioavailability administered as part of a fixed-dose combination with lamivudine and tenofovir disoproxil fumarate

Trial Profile

An open label, randomized , crossover trial to assess the effect of food on Doravirine bioavailability administered as part of a fixed-dose combination with lamivudine and tenofovir disoproxil fumarate

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Doravirine/lamivudine/tenofovir disoproxil fumarate (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 06 Apr 2017 New trial record
    • 27 Mar 2017 Results assessing Doravirine bioavailability from this and other trial ( MK-1439-037) published in the Clinical Drug Investigation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top